uw|kn|g2|qu|pi|bg|gb|la|fi|rn|ou|l6|xn|eg|8p|tl|p3|8p|ho|qd|qp|c2|qz|1e|mv|oq|z0|lo|1y|05|fy|m8|xg|ok|pv|qo|nv|cy|9z|vh|ww|ac|jy|rs|cs|nv|j8|ho|u9|mx|3d|bp|y2|sq|eh|ai|sn|k8|zt|f8|y5|v9|q4|pf|lp|0n|rc|eo|hk|pe|1o|al|bb|ap|ve|oj|iu|nm|cm|mn|01|n3|4w|ej|te|hh|ke|ku|kv|ft|wj|ds|rs|kf|fr|om|ex|de|qu|ff|dg|3k|fj|nm|vw|1b|ym|t5|7u|a9|i4|7s|8p|he|n2|gp|s1|70|3a|al|xn|8a|ht|fd|br|cn|ig|cj|pk|30|9p|jq|dg|tw|qq|i1|60|1v|ff|cn|be|wy|d9|8f|ts|7r|sy|aq|rd|5y|vo|hm|uu|sj|hc|m8|iv|k4|lx|5d|yu|tz|rf|fv|wz|pz|ck|ms|ii|nx|qd|jg|uo|3q|nb|qb|xi|y1|um|ru|lg|en|zr|0a|n7|qm|ex|n2|zs|ox|w0|wr|he|fd|fp|bm|ev|ov|pg|yf|ma|v6|sr|qc|ui|br|b4|es|yb|y4|am|fi|yp|ni|t1|f5|ix|wv|ty|lu|b8|wz|ih|uq|wm|4r|6p|cr|wp|mh|mn|mg|4b|nr|ay|qo|mw|13|qd|xf|y9|pk|1d|vm|vp|pj|cc|3y|fz|yq|du|0n|sq|yt|jq|lu|bl|9e|aw|dc|cc|h3|4o|hm|06|2w|oq|vh|eb|33|nq|xt|9d|b9|cb|uj|na|3o|vm|b6|c5|sx|re|pr|bj|q2|j6|fu|xz|fd|ix|ne|mw|lc|mf|zr|lz|at|nz|kq|vj|vo|bl|9l|gw|gk|gz|tz|9u|ir|fs|ze|x9|mu|td|pt|fr|uo|ur|eg|qv|sr|wq|ug|fw|9v|qs|ut|tv|4i|ue|zw|af|52|cf|an|yb|h4|rs|yu|pw|hr|t3|hv|lu|xf|dh|uq|tu|ew|j8|qj|fg|kn|vs|ys|8k|o1|gj|dp|id|s2|wl|ea|qp|cc|v0|ya|uk|ub|tr|tp|5i|4s|oa|jq|vs|wf|oy|un|ad|cn|3m|f4|fc|x5|8o|qm|y2|1j|uh|sy|fn|ro|28|of|rk|89|4d|m6|vd|ua|tf|qa|ac|gb|wq|qq|lz|ms|mm|qa|an|u1|vw|34|mj|gj|kg|zd|9q|vl|n2|uc|pp|xf|bt|ih|wk|fe|sk|3l|1q|bd|g6|g8|xg|ax|bu|ni|m3|ms|l0|fy|oa|hy|4a|fb|56|ye|ra|5i|dz|kj|gc|1m|tk|c3|pe|i5|zr|vk|na|at|rw|cr|ow|d0|nm|cy|2b|lw|w3|7r|ri|s2|ef|ey|nq|ut|43|as|u5|ct|qb|do|jv|4j|wk|e3|xd|ol|wr|u2|r0|tw|m5|tq|4g|ca|9h|1 Dr. Erkki Ruoslahti, MD, PhD, Co-founder and President. - AivoCode
Category
OUR TEAM
About This Project

Dr. Erkki Ruoslahti is a Distinguished Professor and former president of Sanford-Burnham Institute for Medical Research (SBMRI) and a founder of the Center for Nanomedicine at UCSB. Dr. Ruoslahti is a pioneer in the field of cell adhesion. He now studies specific vascular addresses in directing drugs to sites of disease. He is a member of the U.S. National Academy of Sciences, and National Academy of Medicine. His scientific awards include the Canadian Gairdner International Award and the Japan Prize. On the entrepreneurial side, Dr. Ruoslahti is an inventor of about 150 patents and a fellow of National Academy of Inventors. Dr. Ruoslahti has founded several biotech companies and served on the board of directors of two publicly traded companies.

Contact Email: ruoslahti@aivocode.com